Related Experiment Video
Updated: May 13, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
910
Deep learning for Parkinson's disease classification using multimodal and multi-sequences PET/MR images
Yan Chang1,2, Jiajin Liu3, Shuwei Sun3
1Medical School of Chinese PLA, Beijing, China.
EJNMMI Research
|May 9, 2025
Summary
Deep learning accurately differentiates Parkinson's disease (PD) from multiple system atrophy (MSA) using multi-modal imaging. The combined 11C-CFT and ADC model achieved high accuracy, aiding in diagnosing these similar neurological conditions.
Area of Science:
- Neurology
- Medical Imaging
- Artificial Intelligence
Background:
- Parkinson's disease (PD) and multiple system atrophy (MSA) exhibit overlapping clinical symptoms, complicating differential diagnosis.
- Deep learning (DL) offers a promising approach for distinguishing between PD and MSA.
Purpose of the Study:
- To develop and evaluate a DL model for accurate classification of PD, MSA, and normal controls (NC).
- To assess the performance of multi-modal imaging in differentiating PD from MSA.
Main Methods:
- Retrospective analysis of 206 patients (PD/MSA) and 38 NC using PET/MR imaging.
- Training a modified 18-layer Residual Block Network (ResNet18) on 2D multi-modal image slices.
- Utilizing a four-fold cross-validation and evaluating performance with accuracy, precision, recall, F1 score, ROC, and AUC.
Main Results:
- Multi-modal models, particularly those combining PET and MRI data, outperformed single-modal approaches.
- The 11C-CFT and Apparent Diffusion Coefficient (ADC) multi-modal model demonstrated superior classification performance.
- The best-performing model achieved 0.97 accuracy, 0.93 precision, 0.95 recall, 0.92 F1, and 0.96 AUC in the training set.
Conclusions:
- The developed DL method shows significant potential as an assistive tool for accurate PD and MSA diagnosis.
- Multi-modal and multi-sequence DL models can enhance the classification accuracy for PD and related disorders.
Related Concept Videos
Parkinson's Disease: Overview
323
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
323
Parkinson's Disease: Treatment
154
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
154
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K

